Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001658933 | SCV001874164 | likely pathogenic | not provided | 2021-06-22 | criteria provided, single submitter | clinical testing | Not observed in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 11058904, 11967008) |
Fulgent Genetics, |
RCV002477876 | SCV002788111 | likely pathogenic | Polycystic kidney disease, adult type | 2021-11-19 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003405744 | SCV004104468 | likely pathogenic | PKD1-related disorder | 2023-07-19 | criteria provided, single submitter | clinical testing | The PKD1 c.11555T>C variant is predicted to result in the amino acid substitution p.Leu3852Pro. This variant has been reported to segregate in the heterozygous state with three affected and one unaffected individuals from a single family with autosomal dominant polycystic kidney disease (described as c.11552T>C, Family PKDFe18, Aguiari. 2000. PubMed ID: 11058904). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as likely pathogenic. |